These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12946311)

  • 1. Engraftment of retroviral EGFP-transduced bone marrow in mice prevents rejection of EGFP-transgenic skin grafts.
    Andersson G; Denaro M; Johnson K; Morgan P; Sullivan A; Houser S; Patience C; White-Scharf ME; Down JD
    Mol Ther; 2003 Sep; 8(3):385-91. PubMed ID: 12946311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice.
    Andersson G; Illigens BM; Johnson KW; Calderhead D; LeGuern C; Benichou G; White-Scharf ME; Down JD
    Blood; 2003 Jun; 101(11):4305-12. PubMed ID: 12576326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance by selective in vivo expansion of foreign major histocompatibility complex-transduced autologous bone marrow.
    Zhang JL; Cai J; Walls S; Jackson JD; Kuszynski CA; Zhao Y; Pawliuk R; Leboulch P; Fox IJ
    Transplantation; 2005 Aug; 80(3):362-9. PubMed ID: 16082332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene.
    Puig T; Kádár E; Limón A; Cancelas JA; Eixarch H; Luquín L; García M; Barquinero J
    Gene Ther; 2002 Nov; 9(21):1472-9. PubMed ID: 12378410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer.
    Tian C; Bagley J; Kaye J; Iacomini J
    J Gene Med; 2003 May; 5(5):359-65. PubMed ID: 12731084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
    Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV
    Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
    Kanamoto A; Maki T
    J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological behavior of enhanced green fluorescent protein (EGFP) as a minor histocompatibility antigen with a special reference to skin isograft and specific regulation of local graft-versus-host reaction (GvHR).
    Pan XC; Deng YB; Sugawara Y; Makuuchi M; Okabe M; Ochiya T; Sugiura W; Kitazawa Y; Fuji N; Li XK; Miyamoto M; Kimura H
    Immunol Lett; 2009 Apr; 123(2):103-13. PubMed ID: 19428557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.
    Eixarch H; Gómez A; Kádár E; George M; Martínez N; Espejo C; Pétriz J; Gimeno R; Barquinero J
    Mol Ther; 2009 Nov; 17(11):1904-9. PubMed ID: 19707185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term engraftment of precultured post-5-fluorouracil allogeneic marrow in mice conditioned with a nonmyeloablative regimen: relevance for a gene therapy approach to tolerance induction.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Transpl Immunol; 1996 Mar; 4(1):86-90. PubMed ID: 8762020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy.
    Bagley J; Tian C; Sachs DH; Iacomini J
    Blood; 2002 Jun; 99(12):4394-9. PubMed ID: 12036867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
    Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
    J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent acceptance of both cardiac and skin allografts using a mild conditioning regimen for the induction of stable mixed chimerism in mice.
    van Pel M; Hilbrands L; Smits D; van Breugel DW; van Eck M; Boog CJ
    Transpl Immunol; 2003; 11(1):57-63. PubMed ID: 12727476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells.
    Umemura A; Monaco AP; Maki T
    J Immunol; 2000 May; 164(9):4452-7. PubMed ID: 10779744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of specific prolongation of class I-mismatched skin grafts induced by retroviral gene therapy.
    Mayfield RS; Hayashi H; Sawada T; Bergen K; LeGuern C; Sykes M; Sachs DH; Iacomini J
    Eur J Immunol; 1997 May; 27(5):1177-81. PubMed ID: 9174608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway.
    Fraser CC; Sykes M; Lee RS; Sachs DH; LeGuern C
    J Immunol; 1995 Feb; 154(4):1587-95. PubMed ID: 7836744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of alloreactive CD4 T cell tolerance in molecular chimeras: a possible role for regulatory T cells.
    Forman D; Kang ES; Tian C; Paez-Cortez J; Iacomini J
    J Immunol; 2006 Mar; 176(6):3410-6. PubMed ID: 16517709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.